In the acute treatment cohort, we confirmed by immunohistochemical staining a significant reduction of F4/80-positive macrophages accompanied by reduced density of CD31-positive angiogenic vessels and increased staining for tumor-hypoxia (Fig. 5b and Supplementary Fig. 4c). This evidence concerns the gene PECAM1 and neoplasm.